Multidrug resistance protein P-glycoprotein does not recognize nanoparticle C 60: Experiment and modeling

Soft Matter

Volumn 8, Issue 10, 2012, Pages 2915-2923

  Xu, Xue ^a   Li, Ruibin ^b   Ma, Ming ^a   Wang, Xia ^a   Wang, Yonghua ^a   Zou, Hanfa ^b  

^a NORTHWEST A F UNIVERSITY   (China)

^b DALIAN INSTITUTE OF CHEMICAL PHYSICS   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CONFORMATIONAL CHANGE; DEFENSE RESPONSE; IN-VITRO; INHIBITION ASSAYS; MOLECULAR DYNAMICS SIMULATIONS; MULTIDRUG RESISTANCE; P-GLYCOPROTEIN; RADIUS OF GYRATION; SMALL MOLECULES; THEORETICAL SIMULATION; XENOBIOTIC COMPOUNDS;

CHEMICAL COMPOUNDS; CYTOLOGY; DRUG DELIVERY; DRUG INTERACTIONS; EXPERIMENTS; GLYCOPROTEINS; MOLECULAR DYNAMICS;

NANOPARTICLES;

EID: 84863229941     PISSN: 1744683X     EISSN: 17446848     Source Type: Journal    
DOI: 10.1039/c2sm06811g     Document Type: Article

References (52)

1. S. Geffeney E. D. Brodie P. C. Ruben E. D. Brodie Mechanisms of adaptation in a predator-prey arms race: TTX-resistant sodium channels Science 2002 297 5585 1336 1339 (Pubitemid 34913169)
2. R. W. Johnstone A. A. Ruefli M. J. Smyth Multiple physiological functions for multidrug transporter P-glycoprotein? Trends Biochem. Sci. 2000 25 1 1 6 (Pubitemid 30060419)
3. A. T. Fojo K. Ueda D. J. Slamon D. G. Poplack M. M. Gottesman I. Pastan Expression of a multidrug-resistance gene in human tumors and tissues Proc. Natl. Acad. Sci. U. S. A. 1987 84 265 269 (Pubitemid 17013615)
4. K. Ueda C. Cardarelli M. M. Gottesman I. Pastan Expression of a full-length cDNA for the human "MDR1" gene confers resistance to colchicine, doxorubicin, and vinblastine Proc. Natl. Acad. Sci. U. S. A. 1987 84 3004 3008 (Pubitemid 17064766)
5. P. Gros Y. B. Ben Neriah J. M. Croop D. E. Housman Isolation and expression of a complementary DNA that confers multidrug resistance Nature 1986 323 728 731 (Pubitemid 17172974)
6. J. H. Gerlach J. A. Endicott P. F. Juranka G. Henderson F. Sarangi K. L. DeucAars V. Ling Homology between P-glycoprotein and a bacterial haemolysin transport protein suggests a model for multidrug resistance Nature 1986 324 485 489 (Pubitemid 17184171)
7. X. Xu J. Fu H. Wang B. Zhang X. Wang Yh. Wang Influence of P-glycoprotein on embryotoxicity of the antifouling 4 biocides to sea urchin (Strongylocentrotus intermedius) Ecotoxicology 2011 20 2 419 428
8. K. Terasaka J. J. Blakeslee B. Titapiwatanakun W. A. Peer A. Bandyopadhyay S. N. Makam O. R. Lee E. L. Richards A. S. Murphy F. Sato K. Yazaki PGP4, an ATP binding cassette P-glycoprotein, catalyzes auxin transport in Arabidopsis thaliana roots Plant Cell 2005 17 2922 2939
9. Y. H. Wang Y. Li S. L. Yang L. Yang Classification of substrates and inhibitors of P-glycoprotein using unsupervised machine learning approach J. Chem. Inf. Model. 2005 45 3 750 757 (Pubitemid 40795178)
10. J. K. Vasir V. Labhasetwar Targeted drug delivery in cancer therapy Technology in Cancer Research and Treatment 2005 4 363 374 (Pubitemid 41242611)
11. J. S. Ross D. P. Schenkein R. Pietrusko M. Rolfe G. P. Linette J. Stec N. E. Stagliano Ginsburg W. F. Symmans L. Pusztai G. N. Hortobagyi Targeted therapies for cancer 2004 Am. J. Clin. Pathol. 2004 122 598 609 (Pubitemid 39281258)
12. T. Xia N. Li A. E. Nel Potential health impact of nanoparticles Annu. Rev. Public Health 2009 30 137 150
13. H. J. Johnston G. R. Hutchison F. M. Christensen K. Aschberger V. Stone The biological mechanisms and physicochemical characteristics responsible for driving fullerene toxicity Toxicol. Sci. 2010 114 2 162 182
14. G. K. Bonn R. Bakry R. M. Vallant M. Najam-ul-Haq M. Rainer Z. Szabo C. W. Huck Medicinal applications of fullerenes International Journal of Nanomedicine 2007 2 4 639 649
15. L. E. Murr E. V. Esquivel J. J. Bang G. de la Rosa J. L. Gardea-Torresdey Chemistry and nanoparticulate compositions of a 10,000 year-old ice core melt water Water Res. 2004 38 4282 4296 (Pubitemid 39370938)
16. F. E. Koehn G. T. Carter The evolving role of natural products in drug discovery Nat. Rev. Drug Discovery 2005 4 206 220 (Pubitemid 40372555)
17. R. B. Li R'A Wu L. Zhao M. H. Wu L. Yang H. F. Zou P-Glycoprotein antibody functionalized carbon nanotube overcomes the multidrug resistance of human Leukemia cells ACS Nano 2010 4 3 1399 1408
18. M. J. Later E. M. Amphlett D. M. Andrews G. Bravi G. Burton A. G. Cheasty J. A. Corfield M. R. Ellis R. H. Fenwick S. Fernandes R. Guidetti D. Haigh C. D. Hartley P. D. Howes D. L. Jackson R. L. Jarvest V. L. Lovegrove K. J. Medhurst N. R. Parry H. Price P. Shah O. M. Singh R. Stocker P. Thommes C. Wilkinson A. Wonacott Optimization of novel acyl pyrrolidine inhibitors of hepatitis C virus RNA-dependent RNA polymerase leading to a development candidate J. Med. Chem. 2007 50 897 900 (Pubitemid 46393992)
19. T. Schwede J. Kopp N. Guex M. C. Peitsch SWISS-MODEL: An automated protein homology-modeling server Nucleic Acids Res. 2003 31 3381 3385 (Pubitemid 37442164)
20. R. W. Hooft G. Vriend C. Sander E. E. Abola Errors in protein structures Nature 1996 381 272 272
21. H. Heller M. Schaefer K. Schulten Molecular dynamics simulation of a bilayer of 200 lipids in the gel and in the liquid crystal-phases J. Phys. Chem. 1993 97 8343 8360
22. L. Islas F. Sigworth Electrostatics and the gating pore of shaker potassium channels J. Gen. Physiol. 2001 117 69 89 (Pubitemid 32061907)
23. S. G. Aller J. Yu A. Ward Y. Weng S. Chittaboina R. Zhuo P. M. Harrell Y. T. Trinh I. L. Urbatsch G. Chang Structure of P-Glycoprotein reveals a molecular basis for poly-specific drug binding Science 2009 323 5922 1718 1722
24. A. D. MacKerell Jr D. Bashford M. Bellott R. L. Dunbrack Jr J. D. Evanseck M. J. Field S. Fischer J. Gao H. Guo S. Ha D. Joseph-McCarthy L. Kuchnir K. Kuczera F. T. K. Lau C. Mattos S. Michnick T. Ngo D. T. Nguyen B. Prodhom W. E. Reiher III B. Roux M. Schlen-krich J. C. Smith R. Stote J. Straub M. Watanabe J. Wiorkiewicz-Kuczera D. Yin M. Karplus All-atom empirical potential for molecular modeling and dynamics studies of proteins J. Phys. Chem. B 1998 102 18 3586 3616 (Pubitemid 128576688)
25. 60 in the gas and solid phases J. Phys. Chem. 1992 96 858 861
26. J. C. Phillips R. Braun W. Wang J. Gumbart E. Tajkhorshid E. Villa C. Chipot R. D. Skeel L. Kale K. J. Schulten Scalable molecular dynamics with NAMD J. Comput. Chem. 2005 26 1781 1802 (Pubitemid 43078511)
27. A. D. MacKerell N. Banavali N. Foloppe Development and current status of the CHARMM force field for nucleic acids Biopolymers 2000 56 257 265 (Pubitemid 34105873)
28. A. D. MacKerell Jr. M. Feig C. L. Brooks III Extending the treatment of backbone energetics in protein force fields: Limitations of gas-phase quantum mechanics in reproducing protein conformational distributions in molecular dynamics simulations J. Comput. Chem. 2004 25 1400 1415
29. U. Essmann L. Perera M. L. Berkowitz T. Darden H. Lee L. G. Pedersen A smooth particle mesh Ewald method J. Comput. Phys. 1995 103 8577 8593
30. J. P. Ryckaert G. Ciccotti H. J. C. Berendsen Numerical integration of the cartesian equations of motion of a system with constraints: molecular dynamics of n-alkanes J. Comput. Phys. 1977 23 327 341
31. H. C. Andersen Rattle: a "velocity" version of the shake algorithm for molecular dynamics calculations J. Comput. Phys. 1983 52 24 34
32. C. W. Isaacson C. Y. Usenko R. L. Tanguay J. A. Field Quantification of fullerenes by LC/ESI-MS and its application to in vivo toxicity assays Anal. Chem. 2007 79 9091 9097 (Pubitemid 350231720)
33. D. L. Cox J. D. Radolf Insertion of fluorescent fatty acid probes into the outer membranes of the pathogenic spirochaetes Treponema pallidum and Borrelia burgdorferi Microbiology 2001 147 1161 1169 (Pubitemid 32454634)
34. I. C. van der Sandt M. C. Blom-Roosemalen A. G. de Boer D. D. Breimer Specificity of doxorubicin versus rhodamine-123 in assessing P-glycoprotein functionality in the LLC-PK1, LLC-PK1:MDR1 and Caco-2 cell lines Eur. J. Pharm. Sci. 2000 11 207 214 (Pubitemid 30616443)
35. P. P. Annaert K. L. R. Brouwer Assessment of drug interactions in hepatobiliary transport using Rhodamine-123 in sandwich-cultured rat hepatocytes Drug Metab. Dispos. 2004 33 3 388 394 (Pubitemid 40279939)
36. P. Pavek F. Staud Z. Fendrich H. Sklenarova A. Libra M. Novotna M. Kopecky M. Nobilis V. Semecky Examination of the functional activity of P-glycoprotein in the rat placental barrier using Rhodamine 123 J. Pharmacol. Exp. Ther. 2003 305 3 1239 1250 (Pubitemid 36618004)
37. H. A. Namanja D. Emmert M. M. Pires C. A. Hrycyna J. Chmielewski Inhibition of human P-glycoprotein transport and substrate binding using a galantamine dimer Biochem. Biophys. Res. Commun. 2009 388 4 672 676
38. S. K. Sahoo V. Labhasetwar Enhanced antiproliferative activity of transferrin-conjugated paclitaxel-loaded nanoparticles is mediated via sustained intracellular drug retention Mol. Pharmaceutics 2005 2 373 383 (Pubitemid 41503678)
39. M. D. Chavanpatil A. Khdair B. Gerard C. Bachmeier D. W. Miller M. P. V. Shekhar J. Panyam Surfactant-polymer nanoparticles overcome P-glycoprotein- mediated drug efflux Mol. Pharmaceutics 2007 4 5 730 738 (Pubitemid 350004273)
40. Y. J. Gu J. Cheng C. W. Y. Man W. T. Wong S. H. Cheng Gold-doxorubicin nanoconjugates for overcoming multidrug resistance Nanomedicine: Nanotechnology, Biology, and Medicine 2011
41. M. M. Gottesman T. Fojo S. E. Bates Multidrug resistance in cancer: role of ATP-dependent transporters Nat. Rev. Cancer 2002 2 48 58 (Pubitemid 37328807)
42. B.-X. Chen S. R. Wilson M. Das D. J. Couglin B. F. Erlanger Antigenicity of fullerenes: antibodies specific for fullerenes and their characteristics Proc. Natl. Acad. Sci. U. S. A. 1998 95 10809 10813 (Pubitemid 28413150)
43. S. Kozyrev P. Yakutseni Nanocarbon technologies: prospects and risks NATO Sci. Peace Secur. Ser. B: Phys. Biophys. 2009 9 18
44. A. Aszalos Drug-drug interactions affected by the transporter protein, P-glycoprotein (ABCB1, MDR1): II. Clinical aspects Drug Discovery Today 2007 12 19-20 838 843 (Pubitemid 47539962)
45. A. B. Shapiro V. Ling Positively cooperative sites for drug transport by P-glycoprotein with distinct drug specificitie Eur. J. Biochem. 1997 250 130 137 (Pubitemid 27504592)
46. X. Xu X. Wang Z. Xiao Y. Li Yh Wang Two TPX2-dependent switches control the activity of Aurora A Plos one 2011 6 2 1 7
47. X. Xu W. Yang X. Wang Y. Li Y. Wang C. Ai Dynamic communication between androgen and coactivator: mutually induced conformational perturbations in androgen receptor ligand-binding domain Proteins: Struct., Funct., Bioinf. 2011 79 4 1154 1171
48. A. L. Milac1 N. V. Buchete T. A. Fritz1 G. Hummer L. A. Tabak Substrate-induced conformational changes and dynamics of UDP-N- Acetylgalactosamine: Polypeptide N-Acetylgalactosaminyltransferase-2 J. Mol. Biol. 2007 373 439 451 (Pubitemid 47445582)
49. T. W. Loo D. M. Clarke Determining the dimensions of the drug-binding domain of human P-glycoprotein using thiol cross-linkers as molecular rulers J. Biol. Chem. 2001 276 36877 36880
50. H. Venter R. A. Shilling S. Velamakanni L. Balakrishnan H. W. Van Veen An ABC transporter with a secondary-active multidrug translocator domain Nature 2003 426 866 870 (Pubitemid 38056875)
51. J. A. Sheps S. Ralph Z. Zhao D. L. Baillie V. Ling The ABC transporter gene family of Caenorhabditis elegans has implications for the evolutionary dynamics of multidrug resistance in eukaryotes GenomeBiology 2004 5 3 R15
52. T. V. Karpinets B. D. Foy Tumorigenesis: the adaptation of mammalian cells to sustained stress environment by epigenetic alterations and succeeding matched mutations Carcinogenesis 2005 26 8 1323 1334 (Pubitemid 41417874)